Literature DB >> 1374289

Effects of tolerance induction on early cell cycle progression by Th1 clones.

K M Gilbert1, D N Ernst, M V Hobbs, W O Weigle.   

Abstract

Human gamma-globulin (HGG)-specific mouse Th1 clones exposed to tolerogenic signals provided by HGG-pulsed paraformaldehyde-fixed splenocytes (HGG-FAPC) were analyzed for antigen-induced progression through the early phases of the cell cycle. Exposure of Th1 clones to HGG-FAPC in primary cultures inhibits the ability of the clones to synthesize DNA in response to HGG and normal APC in secondary cultures. The Th1 clones in these secondary cultures were found to be blocked in G1a phase as evidenced by cell cycle analysis and by reduced numbers of cells expressing high levels of IL-2R and TfR. This cell cycle blockade of Th1 cells was not observed if the secondary cultures were stimulated with IL-2-containing Con A CM instead of antigen. These data suggest that in our system the inhibition in antigen-induced cell cycle progression associated with Th1 tolerance induction occurs at the G1a/G1b phase transition.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1374289     DOI: 10.1016/0008-8749(92)90155-i

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  3 in total

1.  Transduction of human progenitor hematopoietic stem cells by human immunodeficiency virus type 1-based vectors is cell cycle dependent.

Authors:  R E Sutton; M J Reitsma; N Uchida; P O Brown
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells.

Authors:  Y D Korin; J A Zack
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

3.  p21(Cip1) up-regulated during histone deacetylase inhibitor-induced CD4(+) T-cell anergy selectively associates with mitogen-activated protein kinases.

Authors:  Ayse Selma Dagtas; Kathleen M Gilbert
Journal:  Immunology       Date:  2009-09-11       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.